The Novel Cannabinoid CB1 Receptor Neutral Antagonist AM4113

Molecules, Free Full-Text

Molecules, Free Full-Text

Therapeutic potential of PIMSR, a novel CB1 receptor neutral antagonist, for cocaine use disorder: evidence from preclinical research

PDF) Interference with TGFβ1-Mediated Inflammation and Fibrosis

Negative allosteric modulation of CB1 cannabinoid receptor signaling suppresses opioid-mediated reward - ScienceDirect

PDF) Interference with TGFβ1-Mediated Inflammation and Fibrosis

DDC, Free Full-Text

PDF) Interference with TGFβ1-Mediated Inflammation and Fibrosis Underlies Reno-Protective Effects of the CB1 Receptor Neutral Antagonists AM6545 and AM4113 in a Rat Model of Metabolic Syndrome

Intracerebroventricular administration of cannabinoid CB1 receptor antagonists AM251 and AM4113 fails to alter food-reinforced behavior in rats

Frontiers The Cannabinoid CB1 Antagonist TM38837 With Limited Penetrance to the Brain Shows Reduced Fear-Promoting Effects in Mice

The Novel Cannabinoid CB1 Receptor Neutral Antagonist AM4113 Suppresses Food Intake and Food-Reinforced Behavior but Does not Induce Signs of Nausea in Rats

Cannabinoid CB1 receptor inverse agonists and neutral antagonists: effects on food intake, food-reinforced behavior and food aversions. - Abstract - Europe PMC

Novel pyrazole derivatives as neutral CB1 antagonists with

Frontiers The Cannabinoid CB1 Antagonist TM38837 With Limited Penetrance to the Brain Shows Reduced Fear-Promoting Effects in Mice